143 related articles for article (PubMed ID: 8596756)
1. [Secretion of atrial natriuretic peptide and vasopressin during hemodialysis in patients with chronic renal failure].
Grzeszczak W; Sornek E; Zukowska-Szczechowska E; Mizera W; Klajnowicz J
Pol Arch Med Wewn; 1995 Sep; 94(3):195-207. PubMed ID: 8596756
[TBL] [Abstract][Full Text] [Related]
2. [Level of atrial natriuretic peptide (ANP) in plasma of patients with chronic renal failure during hemodialysis].
Grzeszczak W; Kowalska K; Zukowska-szczechowska EA; Kowalski D; Snit M; Sornek E
Pol Arch Med Wewn; 1995 Feb; 93(2):107-13. PubMed ID: 7479227
[TBL] [Abstract][Full Text] [Related]
3. [Levels of endothelin and atrial natriuretic peptide (ANP) in plasma of patients with chronic renal failure treated by hemodialysis].
Kowalska K; Grzeszczak W; Kowalski D
Pol Arch Med Wewn; 1993 Nov; 90(5):334-41. PubMed ID: 8146034
[TBL] [Abstract][Full Text] [Related]
4. [Response of vasoactive substance to blood pressure changes during hemodialysis in uremic patients].
Witkowicz J; Kokot F; Irzyniec T; Chudek J; Ficek R
Pol Arch Med Wewn; 1999 Sep; 102(3):763-71. PubMed ID: 10949883
[TBL] [Abstract][Full Text] [Related]
5. Fluid balance in patients with chronic renal failure assessed with N-terminal proatrial natriuretic peptide, atrial natriuretic peptide and ultrasonography.
Metry G; Hall C; Wikström B; Källskog V; Hansell P; Danielson B
Acta Physiol Scand; 2001 Feb; 171(2):117-22. PubMed ID: 11350271
[TBL] [Abstract][Full Text] [Related]
6. Plasma levels of atrial natriuretic peptide in patients with chronic renal failure.
Hasegawa K; Matsushita Y; Inoue T; Morii H; Ishibashi M; Yamaji T
J Clin Endocrinol Metab; 1986 Oct; 63(4):819-22. PubMed ID: 2943754
[TBL] [Abstract][Full Text] [Related]
7. Plasma concentrations of atrial natriuretic peptide, arginine vasopressin and hormones of the renin-angiotensin system in patients with end-stage renal disease.
Elias AN; Vaziri ND; Pandian MR; Kaupke J
Int J Artif Organs; 1989 Mar; 12(3):153-8. PubMed ID: 2526100
[TBL] [Abstract][Full Text] [Related]
8. Atrial natriuretic peptide (ANP) in patients with chronic renal failure on maintenance haemodialysis.
de Châtel R; Makó J; Tóth M; Barna I; Lang RE
Int Urol Nephrol; 1991; 23(2):177-83. PubMed ID: 1830872
[TBL] [Abstract][Full Text] [Related]
9. Plasma atrial natriuretic peptide in patients with chronic renal failure.
Chen JH; Tsai JH; Lai YH; Hwang SJ
J Formos Med Assoc; 1990 Aug; 89(8):645-50. PubMed ID: 1981224
[TBL] [Abstract][Full Text] [Related]
10. Water immersion-induced alterations of plasma atrial natriuretic peptide level and its relationship to the renin-angiotensin-aldosterone system and vasopressin secretion in acute and chronic renal failure.
Kokot F; Grzeszczak W; Zukowska-Szczechowska E; Wiecek A
Clin Nephrol; 1989 May; 31(5):247-52. PubMed ID: 2525441
[TBL] [Abstract][Full Text] [Related]
11. Atrial natriuretic peptide in renal transplantation.
Plum J; Scholtz W; Grabensee B
Horm Res; 1996; 46(2):74-82. PubMed ID: 8871185
[TBL] [Abstract][Full Text] [Related]
12. Influence of erythropoietin treatment on plasma renin activity, aldosterone, vasopressin and atrial natriuretic peptide in haemodialyzed patients.
Kokot F; Wiecek A; Grzeszczak W; Klin M
Miner Electrolyte Metab; 1990; 16(1):25-9. PubMed ID: 2139159
[TBL] [Abstract][Full Text] [Related]
13. Plasma brain natriuretic peptide levels in chronic hemodialysis patients: influence of coronary artery disease.
Nishikimi T; Futoo Y; Tamano K; Takahashi M; Suzuki T; Minami J; Honda T; Uetake S; Asakawa H; Kobayashi N; Horinaka S; Ishimitsu T; Matsuoka H
Am J Kidney Dis; 2001 Jun; 37(6):1201-8. PubMed ID: 11382689
[TBL] [Abstract][Full Text] [Related]
14. Renal and hemodialysis clearances of endogenous natriuretic peptide. A clinical and experimental study.
Deray G; Maistre G; Cacoub P; Barthelemy C; Eurin J; Carayon A; Masson F; Martinez F; Baumelou A; Legrand JC
Nephron; 1990; 54(2):148-53. PubMed ID: 2138254
[TBL] [Abstract][Full Text] [Related]
15. Neuroendocrinology of chronic renal failure and renal transplantation.
Crum R; Fairchild R; Bronsther O; Dominic W; Ward D; Fernandez R; Brown MR
Transplantation; 1991 Nov; 52(5):818-23. PubMed ID: 1835195
[TBL] [Abstract][Full Text] [Related]
16. Atrial natriuretic peptide in patients with the syndrome of inappropriate antidiuretic hormone secretion and with diabetes insipidus.
Kamoi K; Ebe T; Kobayashi O; Ishida M; Sato F; Arai O; Tamura T; Takagi A; Yamada A; Ishibashi M
J Clin Endocrinol Metab; 1990 May; 70(5):1385-90. PubMed ID: 2139879
[TBL] [Abstract][Full Text] [Related]
17. Changes in brain natriuretic peptide and atrial natriuretic peptide plasma concentrations during hemodialysis in patients with chronic renal failure.
Haug C; Metzele A; Steffgen J; Grünert A
Horm Metab Res; 1994 May; 26(5):246-9. PubMed ID: 8076909
[TBL] [Abstract][Full Text] [Related]
18. Plasma concentrations of natriuretic peptides in patients on hemodialysis.
Takahashi M; Nagake Y; Ichikawa H; Kawabata K; Nakazono H; Hirata K; Ogura T; Makino H
Res Commun Mol Pathol Pharmacol; 1996 Apr; 92(1):19-30. PubMed ID: 8733825
[TBL] [Abstract][Full Text] [Related]
19. Plasma levels of atrial natriuretic peptide and digoxin-like immunoreactive substances in intermittent peritoneal dialysis.
Korzets Z; Pomeranz M; Shilo L; Pomeranze A; Levi A; Shenkman L; Berheim J
Adv Perit Dial; 1989; 5():20-3. PubMed ID: 2577411
[TBL] [Abstract][Full Text] [Related]
20. Response of vasoactive substances to intermittent ultrafiltration in normotensive hemodialysis patients.
Heintz B; Königs F; Dakshinamurty KV; Kierdorf H; Gladziwa U; Kirsten R; Nelson K; Wieland D; Riehl J; Mann H
Nephron; 1993; 65(2):266-72. PubMed ID: 8247191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
